$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Sep 26, 2025)
$9.77M
Market Cap
-
P/E Ratio
-19.25
EPS
$21.78
52 Week High
$1.62
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Dogwood Therapeutics, Inc. is a development-stage biotechnology company based in Alpharetta, Georgia, dedicated to pioneering innovative antiviral therapies aimed at addressing diseases linked to abnormal immune responses triggered by viral infections. With a strategic focus on harnessing cutting-edge research and technologies, Dogwood Therapeutics aims to advance its pipeline of therapeutic candidates that may revolutionize treatment options for patients with these challenging conditions. As the company progresses through preclinical and clinical stages, it seeks to fulfill its mission of enhancing patient outcomes and contributing to the broader fight against viral diseases.